Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Lawmakers seek scientific review of plan to tightly regulate all fentanyl copycats

Lawmakers on the U.S. Senate Judiciary Committee urged the Trump administration to conduct a scientific review of a Justice Department-backed bill to classify all illicit chemical knockoffs of the potent painkiller fentanyl in the same legal category as heroin.

Read More »

As measles returns, U.S. states look to cut vaccine exemptions

Maine could soon prohibit parents from citing religious or personal beliefs to avoid vaccinating their children, making the U.S. state one of a half dozen cracking down during the nations’ largest measles outbreak in 25 years.

Read More »

Data Privacy Legislation Picking Up Speed: State and Federal Update

The data privacy landscape in the U.S. is continuing to change rapidly.

Read More »

Breast Ultrasound and Cancer Detection Rates Increased Under New Laws

  Participating in the Blue Cross Blue Shield Alliance for Health Research, the study comes from Yale’s School of Public Health and School of Medicine   NEW HAVEN, Conn., March 22, 2019 /PRNewswire/ –State breast density notification laws that mandate reporting of mammogram results can prompt further screening and modestly boost cancer detection rates, say […]

Read More »

Voters in Maine approve expansion of Medicaid under Obamacare

Voters in Maine approved a ballot initiative to expand the state’s Medicaid program under Obamacare, sending a clear signal of support for the federal healthcare law to lawmakers in the state and Washington D.C.

Read More »

Novo Nordisk warns of U.S. legislation

Drugmaker Novo Nordisk warned that draft legislation in some U.S. states to make pricing more transparent could impact business in the company’s largest market.

Read More »

Trump’s drug czar nominee withdraws from consideration

President Donald Trump’s pick for U.S. drug czar withdrew after it become public that he spearheaded a bill that undercut the government’s power to crack down on opioid makers that were flooding the market with the addictive painkillers.

Read More »

Pharma Scores Big Win: Trump to Ink FDA User Fee Bill, Saving 5,000 Jobs

Hours before the U.S. Senate recessed for the remainder of summer 2017, legislators approved key legislation that will provide the necessary funding to keep the U.S. FDA operating efficiently.

Read More »

U.S. House panel spotlights use of FDA rules to slow generic drugs

Republican and Democratic lawmakers discussed ways to prevent drugmakers from using rules developed to safeguard patients to instead block the sale of cheaper medicines.

Read More »

U.S. Senate Republicans set repeal vote as healthcare overhaul sinks

  By Susan Cornwell   WASHINGTON (Reuters) – U.S. Senate Republicans will vote on a straight repeal of Obamacare after efforts to overhaul the law collapsed, rattling financial markets on Tuesday and clouding the path forward for President Donald Trump’s other domestic policy goals. After two Republicans said they would not back the latest Obamacare […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom